Close Menu

UMass

RNAi Grant Roundup

Premium

Key RNAi-related grants issued by the National Institutes of Health thus far this year.

IP Update: Apr 23, 2009

Premium

USPTO Publishes Two Patents, Sixteen Patent Applications Related to RNAi

Merck, Medarex, and UMass' MBL Ink mAb deal; Vandy licenses cancer Rx assay to DiaTech; MolecularMD sub-licenses OHSU CML mutation test to Mayo Clinic, and more …

Shire Owings Mills (Md.) Plant, Alexandria Real Estate Equities, Takeda Pharmaceutical, Wareham Development, PATH, Fall River (Mass.) Executive Park, University of Massachusetts/Dartmouth Bioprocessing Facility, Silicon Border, Sapphire Engineering, Campanelli Business Park, University of California-Davis M.I.N.D., Institute, Doe & Ingalls of North Carolina, Covaris, Life Technologies, BioMed Realty Trust, Shasun Pharma Solutions

The university will lead a multi-center study of large flowering plants seeking genetics behind certain traits.

Regeneron Inks mAb Pact with UT-Southwestern; Mount Sinai taps DiscoveryBioMed for bioassay services; Repligen licenses bipolar disorder Rx from Harvard's McLean, and more …

The company also noted in a filing with the US Securities and Exchange Commission that it continues to seek out industry partnerships after having failed to forge a deal in 2008 as previously anticipated.

Strands: Mar 19, 2009

Premium

Cenix BioScience, AstraZeneca, RXi Pharmaceuticals, Dicerna Pharmaceuticals, Intradigm, US Patent and Trademark Office, Integrated DNA Technologies, VH Bio, Asuragen, Agilent Technologies, Proceedings of the National Academy of Sciences

Millipore Anderson Facility, University of Massachusetts-Lowell Emerging Technology & Innovation Center, Boehringer Ingelheim Chemicals Petersburg, Va., Plant Expansion, Hamner Institutes for Health Sciences, LabCorp Biorepository, North Carolina Research Campus, Rowan-Cabarrus Community College, Economic Development Council of Tallahassee/Leon County, and others

IP Update: Mar 5, 2009

Premium

USPTO Publishes One Patent, Eight Patent Applications Related to RNAi

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.